239 related articles for article (PubMed ID: 26612734)
1. Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.
Watanabe A; Muragaki Y; Maruyama T; Shinoda J; Okada Y
J Neurooncol; 2016 Feb; 126(3):577-83. PubMed ID: 26612734
[TBL] [Abstract][Full Text] [Related]
2. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
3. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
4. Role of [(11)C] methionine positron emission tomography in the diagnosis and prediction of survival in brain tumours.
Cicuendez M; Lorenzo-Bosquet C; Cuberas-Borrós G; Martinez-Ricarte F; Cordero E; Martinez-Saez E; Castell-Conesa J; Sahuquillo J
Clin Neurol Neurosurg; 2015 Dec; 139():328-33. PubMed ID: 26588352
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
6. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
7. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Gempt J; Bette S; Ryang YM; Buchmann N; Peschke P; Pyka T; Wester HJ; Förster S; Meyer B; Ringel F
Eur J Radiol; 2015 May; 84(5):955-62. PubMed ID: 25748815
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.
Takano K; Kinoshita M; Arita H; Okita Y; Chiba Y; Kagawa N; Fujimoto Y; Kishima H; Kanemura Y; Nonaka M; Nakajima S; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
AJNR Am J Neuroradiol; 2016 Jan; 37(1):44-50. PubMed ID: 26381556
[TBL] [Abstract][Full Text] [Related]
10. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
11. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
[TBL] [Abstract][Full Text] [Related]
12. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
13. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.
Ceyssens S; Van Laere K; de Groot T; Goffin J; Bormans G; Mortelmans L
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1432-7. PubMed ID: 16908552
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of post-treatment metabolic tumor volume from
Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY
Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449
[TBL] [Abstract][Full Text] [Related]
15. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
16. (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison.
Okita Y; Kinoshita M; Goto T; Kagawa N; Kishima H; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
Neuroimage; 2010 Feb; 49(4):2977-82. PubMed ID: 19931401
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma.
Nariai T; Tanaka Y; Wakimoto H; Aoyagi M; Tamaki M; Ishiwata K; Senda M; Ishii K; Hirakawa K; Ohno K
J Neurosurg; 2005 Sep; 103(3):498-507. PubMed ID: 16235683
[TBL] [Abstract][Full Text] [Related]
18. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
19. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218
[TBL] [Abstract][Full Text] [Related]
20. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
